CD19 and inflammatory bowel disease: Notably, it has been identified that IBD-related inflammation features mucosal accumulation of cytotoxic, granzyme B-expressing CD19+ and IgA+ cells, suggesting their involvement in IBD-associated epithelial damage (33).